12/3/2012

The U.S. Supreme Court will once again look at the issue of whether human genes are "patent-eligible" material after it issued a writ of certiorari to a group of plaintiffs involved in a breast cancer-genes patent case. The dispute was filed on behalf of a clinician who wants to examine people for breast cancer genes BRCA1 and BRCA2 without a license from Myriad Genetics, which owns the patents for those genes.

Full Story:
ScienceMag.org

Related Summaries